Abstract:Somatic cells could be reprogrammed into an ES-like state called induced pluripotent stem cells (iPSCs) by expression of four transcriptional factors: Oct4, Sox2, Klf4 and cMyc. iPSCs have full potentials to generate cells of all lineages and have become a valuable tool to understand human development and disease pathogenesis. However, reprogramming process suffers from extremely low efficiency and the molecular mechanism remains poorly understood. This dissertation is focused on studying the role of small non-coding RNAs (microRNAs) and kinases during the reprogramming process in order to understand how it is regulated and why only a small percentage of cells could achieve fully reprogrammed state. We demonstrate that loss of microRNA biogenesis pathway abolished the potential of mouse embryonic fibroblasts (MEFs) to be reprogrammed and revealed that several clusters of mES-specific microRNAs were highly induced by four factors during early stage of reprogramming. Among them, miR-93 and 106b were further confirmed to enhance iPSC generation by promoting mesenchymal-to-epithelial transition (MET) and targeting key p53 and TGFβ pathway components: p21 and Tgfbr2, which are important barrier genes to the process. To expand our view of microRNAs function during reprogramming, a systematic approach was used to analyze microRNA expression profile in iPSC-enriched early cell population. From a list of candiate microRNAs, miR-135b was found to be most highly induced and promoted reprogramming. Subsequent analysis revealed that it targeted an extracellular matrix network by directly modulating key regulator Wisp1. By regulating several downstream ECM genes including Tgfbi, Nov, Dkk2 and Igfbp5, Wisp1 coordinated IGF, TGFβ and Wnt signaling pathways, all of which were strongly involved in the reprogramming process. Therefore, we have identified a microRNA-regulated network that modulates somatic cell reprogramming, involving both intracellular and extracellular networks. In addition to microRNAs, in order to identify new regulators and signaling pathways of reprogramming, we utilized small molecule kinase inhibitors. A collection of 244 kinase inhibitors were screened for both enhancers and inhibitors of the process. We identified that inhibition of several novel kinases including p38, IP3K and Aurora kinase could significantly enhance iPSC generation, the effects of which were also confirmed by RNAi of specific target genes. Further characterization revealed that inhibition of Aurora A kinase enhanced phosphorylation and inactivation of GSK3β, a process mediated by Akt kinase. All together, in this dissertation, we have identified novel role of both small non-coding RNAs and kinases in regulating the reprogramming of MEFs to iPSCs.

Comparative analysis of mouse strains for reprogramming

Rapamycin and other longevity-promoting compounds enhance the generation of mouse induced pluripotent stem cells.

In vivo reprogramming of leads to heterogeneous effects on lifespan

Brief Report: Combined Chemical Treatment Enables Oct4-Induced Reprogramming from Mouse Embryonic Fibroblasts

Continuous expression of reprogramming factors induces and maintains mouse pluripotency without specific growth factors and signaling inhibitors

In vivo partial reprogramming alters age-associated molecular changes during physiological aging in mice

Targeted partial reprogramming of age-associated cell states improves markers of health in mouse models of aging

Reprogramming of mouse fibroblasts to an intermediate state of differentiation by chemical induction.

Manipulating cell fate through reprogramming: approaches and applications

Multi-omics characterization of partial chemical reprogramming reveals evidence of cell rejuvenation

Highly Efficient Mirna-Mediated Reprogramming of Mouse and Human Somatic Cells to Pluripotency.

An Optogenetic-Controlled Cell Reprogramming System for Driving Cell Fate and Light-Responsive Chimeric Mice

Dissecting Somatic Cell Reprogramming by MicroRNAs and Small Molecules: A Dissertation

Forkhead Box Family Transcription Factors As Versatile Regulators for Cellular Reprogramming to Pluripotency.

Learning the molecular mechanisms of the reprogramming factors: let's start from microRNAs

Gene Therapy-Mediated Partial Reprogramming Extends Lifespan and Reverses Age-Related Changes in Aged Mice

Temporal Requirements of cMyc Protein for Reprogramming Mouse Fibroblasts

The long and winding road of reprogramming-induced rejuvenation

Identifying Candidate Reprogramming Genes in Mouse Induced Pluripotent Stem Cells

Deciphering the roadmap of in vivo reprogramming toward pluripotency

Pluripotent state induction in mouse embryonic fibroblast using mRNAs of reprogramming factors